SINCLAIR PHARMA is an international specialty pharmaceutical company that provides solutions to treat wounds, and dermatological and oral diseases through the use of advanced surface technology and progressive delivery systems.
The company has a growing sales and marketing operation in the UK which is currently able to supply Kelo-cote self-drying silicone gel. It also offers Flammacerium which is designed for the prevention and treatment of infection in severe burns with deep lesions; CryoSkin Cryopreseved Allogeneic Keratinocytes, for immediate application onto seriously burned patients, which is said to improve healing times by up to 50%; and MySkin Autologous Cells for severely burned patients and hard to heal wounds. It is available in sheets and as a spray. Finally, the company offers Catrix, a collagen based powder designed for wound healing and as an alternative to skin grafting in burn patients.
